一種新型雙極消融系統，能夠幫助醫生更加徹底地消融較厚的和病變更嚴重的組織，使得治療效果更為持久。

Isolator Synergy雙極消融系統，在夾子的狹口處有兩個脈沖電極對，從而產生一致的全厚度消融柱狀病變消融效果，這樣在較厚和病變程度較重的組織能夠進行更持久的消融效果。該系統的狹口較低，便于在病變周圍組織安放和操作。臨床前試驗已經證實，該系統能夠在較厚的組織產生一致的透壁消融效果。Isolator Synergy是美國AtriCure公司 (Cincinnati, OH, USA)的產品，已經得到了美國食品藥品管理局(FDA)的批準，用于消融軟組織。該設備還未獲準用于心肌組織的消融治療。

Bipolar Soft Tissue Ablation System
 
A new bipolar ablation system allows physicians to ensure full thickness ablation of thicker and more diseased tissues and create more durable lines of block.

The Isolator Synergy bipolar ablation system incorporates two pulsing pairs of electrodes in the jaws of the clamp, creating a uniform, full thickness ablation lesion shaped like a column, which results in more durable ablation lines in thicker and more diseased tissues. The system also features a low profile jaw for easier placement and maneuverability around surrounding structures. Pre-clinical studies have demonstrated that the ablation lines are consistently transmural in thicker tissues. The Isolator Synergy is a product of AtriCure (Cincinnati, OH, USA) and has been approved by the U.S. Food and Drug Administration (FDA) for the ablation of soft tissue. The device is not yet cleared for the ablation of cardiac tissue.